Choose It and Use It: Choice, Implementation Intentions and At-Home Colorectal Cancer Screening
Part of paid clinical trials in Flint, Michigan.
- Sponsor
- Michigan State University
- Study ID
- NCT06085560
- Status
- Enrolling By Invitation
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 45 Years - 72 Years
- Healthy Volunteers
- Accepted
Interventions
- Usual Care Message — BEHAVIORALUsual care is provided by the FQHC for the screening option chosen.
- Implementation Intention Intervention: Standard Message — BEHAVIORALImplementation Intention Intervention module includes standard messaging in addition to the usual care provided by the FQHC for the screening option chosen.
- Implementation Intention Intervention: Culturally-Targeted Message — BEHAVIORALImplementation Intention Intervention module includes culturally-targeted framing of health information messages in addition to the usual care provided by the FQHC for the screening option chosen.
Study Details
The goal of this study is to improve use of colorectal cancer screening among screening eligible African Americans who are served by Federally Qualified Health Centers in Michigan. The main questions it aims to answer are: * To what extent to individual prefer and select to complete screening with colonoscopy versus stool-based (FIT Kit or sDNA) options? * Can full completion of (i.e. follow-through with) screening with a selected modality be enhanced by delivery of a culturally targeted intervention? Participants will learn about colonoscopy, FIT Kit and sDNA as recommended and widely used screening options. Participants will select a modality to complete their own screening with. Participants will then be randomized to one of three arms (usual care, standard intervention, culturally targeted intervention). Researchers will compare the extent to which intervention arms enhance completion rates across each of the three screening modalities.
Key Dates
- Start date
- Jul 12, 2023
- Status verified
- May 2026
- Primary completion
- Jun 30, 2027
- Completion
- Jun 30, 2027
Study Design
- Enrollment
- 600 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- FACTORIAL
- Primary purpose
- SCREENING
Arms
- Active Comparator: Usual Care MessageParticipants selecting a colorectal cancer screening will receive "usual care" from the FQHC.
- Active Comparator: Implementation Intention Intervention: Standard MessageParticipants selecting a colorectal cancer screening will receive implementation intention messages in addition to the "usual care" from the FQHC.
- Experimental: Implementation Intention Intervention: Culturally-Targeted MessageParticipants selecting a colorectal cancer screening will receive culturally-targeted implementation intention messages in addition to the "usual care" from the FQHC.
Primary Outcome Measure
Colorectal Cancer Screening Modality Request Rates [ Time Frame: up to 2 weeks ]
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Michigan State University | Flint | Michigan | 48502 | - |
Find similar trials in Flint, MI
Related Studies
- Study of IDE196 in Patients With Solid Tumors Harboring GNAQ/11 Mutations or PRKC FusionsPHASE1/PHASE2 · Recruiting · IDEAYA Biosciences · Los Angeles, California
- Myopenia and Mechanisms of Chemotherapy Toxicity in Older Adults With Colorectal CancerRecruiting · Wake Forest University Health Sciences · Millville, Delaware
- The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)PHASE1/PHASE2 · Recruiting · PMV Pharmaceuticals, Inc · Irvine, California
- Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)PHASE2 · Recruiting · AstraZeneca · Los Angeles, California